| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 3.627 | 12.354 | 16.937 | 28.011 | 21.880 | 20.233 | 20.259 |
| Total Income - EUR | - | - | - | 3.627 | 13.019 | 16.956 | 28.011 | 21.881 | 20.233 | 20.268 |
| Total Expenses - EUR | - | - | - | 2.571 | 10.088 | 9.506 | 9.686 | 8.423 | 9.344 | 8.146 |
| Gross Profit/Loss - EUR | - | - | - | 1.056 | 2.931 | 7.450 | 18.325 | 13.458 | 10.889 | 12.121 |
| Net Profit/Loss - EUR | - | - | - | 947 | 2.545 | 6.965 | 17.502 | 12.815 | 9.021 | 10.291 |
| Employees | - | - | - | 0 | 0 | 0 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Nutrigenomic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 1.183 | 9.800 | 7.267 | 4.224 | 2.225 | 1.095 | 726 |
| Current Assets | - | - | - | 429 | 453 | 3.021 | 13.630 | 11.147 | 8.476 | 10.611 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 238 | 0 | 9.733 | 0 | 11 |
| Cash | - | - | - | 429 | 453 | 2.783 | 13.630 | 1.413 | 8.476 | 10.600 |
| Shareholders Funds | - | - | - | 990 | 2.595 | 7.015 | 17.550 | 12.863 | 9.069 | 11.369 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 622 | 7.659 | 3.274 | 303 | 566 | 596 | 62 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Nutrigenomic S.r.l.